identifying women at risk of preterm birth
|INSTITUTION:||Department of Women and Children’s Health, St Thomas’ Hospital; King’s College London and Institute of Pharmaceutical Science, King’s College London|
|RESEARCHERS:||Professor Rachel Tribe, Dr Natasha Hezelgrave, Professor Andy Shennan, Dr James Mason|
Although the causes of preterm birth are often not understood, one factor may be how a woman’s body deals with mild vaginal infections during pregnancy.
Through this project, jointly funded by Borne and Action Medical Research, Professor Rachel Tribe at King’s College London is aiming to develop a new screening test that can help identify pregnant women who are at increased risk of early delivery.
about the research
We are funding a research group at Imperial College’s laboratory at Chelsea and Westminster Hospital, which is focused on gaining a deeper understanding of the cellular mechanisms controlling healthy birth.
In a project funded by Borne and Action Medical Research in 2017, Professor Tribe’s team are studying exosomes, tiny spherical structures (now known as extracellular vesicles, EVs) that are released from cells in the vagina, cervix and placenta. In response to infections, the EVs alert other cells to produce defences against invading pathogens by releasing their contents (proteins, lipids and micro RNAs).
The team seeks to characterise exosomes found in cervical-vaginal fluid at various stages of pregnancy, hoping to identify a pattern in the exosomes of women most likely to have a preterm birth.
“If we can develop this into a new test for women in early pregnancy, identifying those at risk would enable appropriate steps to be taken to protect their baby from being born too soon.”
– Professor Rachel Tribe
UPDATES & IMPACT
As a result of Borne and Action Medical Research funding, the team has collaborated internationally with other research institutions and established connections with several companies to use cutting edge technologies to determine that the EVs in cervico-vaginal fluid (CVF) are not as originally suggested.
They have analysed CVF samples from pregnant women and have found the small EVs to be even smaller entities /microparticles which seem to be unique – the aim is to publish this work shortly.
The researchers aim, through rigorous experimentation science, to move the field of CVF extracellular vesicles significantly forward by characterising and identifying a new form of EV/microparticle in cervico-vaginal fluid.
The next steps are to revise the methods for isolation, analysis and validation of EVs for samples from more women and ultimately validate a new biomarker for prediction of preterm birth which Professor Tribe hopes will help save children’s lives and reduce the risk of long-term complications from being born too soon.
Other outcomes from the research so far include a successful application for a NIHR Biomedical Research Centre GSTT and KCL Bioinformatics PhD studentship and several keynote presentations at national and international conferences.